当前位置:
X-MOL 学术
›
Nat. Rev. Gastroenterol. Hepatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
IBD in 2017: Development of therapy for and prediction of IBD — getting personal
Nature Reviews Gastroenterology & Hepatology ( IF 45.9 ) Pub Date : 2017-12-06 , DOI: 10.1038/nrgastro.2017.166 Raja Atreya , Britta Siegmund
Nature Reviews Gastroenterology & Hepatology ( IF 45.9 ) Pub Date : 2017-12-06 , DOI: 10.1038/nrgastro.2017.166 Raja Atreya , Britta Siegmund
IBD in 2017: Development of therapy for and prediction of IBD — getting personal
中文翻译:
2017年的IBD:发展IBD的疗法和预测-变得个性化
2017年的IBD:发展IBD的疗法和预测-变得个性化
更新日期:2017-12-06
IBD in 2017: Development of therapy for and prediction of IBD — getting personal, Published online: 06 December 2017; doi:10.1038/nrgastro.2017.166
The central studies published in 2017 address novel IBD therapeutic strategies and prediction of the future disease course or response to a distinct therapy. Together, these studies contribute to the understanding of the regulation of mucosal homeostasis and at the same time serve to develop novel personalized treatment algorithms in patients in whom a severe disease course can be predicted.中文翻译:
2017年的IBD:发展IBD的疗法和预测-变得个性化
2017年的IBD:发展IBD的疗法和预测-变得个性化
2017年的IBD:发展IBD的疗法和预测-变得个性化,在线发布:2017年12月6日;doi:10.1038 / nrgastro.2017.166
2017年发表的中心研究涉及新型IBD治疗策略以及对未来疾病病程或对独特疗法的反应的预测。总之,这些研究有助于理解粘膜稳态的调节,同时有助于开发可预测严重病程的患者的新型个性化治疗算法。